Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00682825 · ClinicalTrials.gov registry record · Phase 4
Study Evaluating Whether the Bispectral Index Prevents Patients at Higher Risk From Being Awake During Surgery and Anesthesia
A Phase 4 study of Explicit Recall of Intra-Operative Events, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 6,000
- Enrollment target
- 3
- Study locations
NCT00682825: Completed Phase 4 study of Explicit Recall of Intra-Operative Events, sponsored by Washington University School of Medicine.
NCT00682825 is a Phase 4 study of Explicit Recall of Intra-Operative Events that has completed, run by Washington University School of Medicine. The registered enrollment target is 6,000 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (1058% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00682825, a Phase 4 study of Explicit Recall of Intra-Operative Events, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 6,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able to measure how asleep a patient is during surgery. Using the BIS monitor to guide anesthesia will be compared with using the concentration of anesthetic gas to guide anesthesia.
Conditions Studied
Interventions
- BEHAVIORAL Bispectral index protocol
- BEHAVIORAL End tidal anesthetic gas-guided
Study Locations (3)
Illinois
- University of Chicago - Chicago
Missouri
- Washington University - St Louis
Manitoba
- University of Manitoba - Winnipeg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
| Start Date | 2008-03 |
| Phase | Phase 4 |
What the finished NCT00682825 record still lists
NCT00682825 is an interventional study that assigns participants to a tested intervention. Its 6,000 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (1058% higher).
The record links to 1 condition, with Explicit Recall of Intra-Operative Events appearing as the primary indexed condition, and to 2 interventions - of which Bispectral index protocol is the first listed.
NCT00682825 reports a single indexed study location in Illinois, Missouri, Manitoba.
Frequently Asked Questions
What is clinical trial NCT00682825 about?
NCT00682825 is a clinical study titled "Study Evaluating Whether the Bispectral Index Prevents Patients at Higher Risk From Being Awake During Surgery and Anesthesia". The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able to measure how asleep a patient is duri...
What is the current status of trial NCT00682825?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 6,000 participants. The study started on 2008-03.
What conditions does trial NCT00682825 study?
This clinical trial studies the following conditions: Explicit Recall of Intra-Operative Events.
What interventions are being tested in trial NCT00682825?
The interventions under investigation include: Bispectral index protocol (BEHAVIORAL), End tidal anesthetic gas-guided (BEHAVIORAL).
Who is sponsoring clinical trial NCT00682825?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00682825 being conducted?
This trial has 3 study locations across Illinois, Missouri, Manitoba. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00682825's enrollment target sits among peer trials
6,000 13th of 2000 higher than 1,986 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
- NCT03127631 · 6,000 participants · NA
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
- NCT03539705 · 6,000 participants
Food Allergy Registry at a Single Site
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia